{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T07:36:28Z","timestamp":1775374588053,"version":"3.50.1"},"reference-count":153,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG018454"],"award-info":[{"award-number":["R01AG018454"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG046139"],"award-info":[{"award-number":["U01AG046139"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50AG047266"],"award-info":[{"award-number":["P50AG047266"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.neuron.2019.02.027","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T12:05:05Z","timestamp":1553083505000},"page":"1003-1015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders"],"prefix":"10.1016","volume":"101","author":[{"given":"Todd E.","family":"Golde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2019.02.027_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","article-title":"iPSC-derived human microglia-like cells to study neurological diseases","volume":"94","author":"Abud","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2019.02.027_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","article-title":"Follow-up evaluation of cognitive function in the randomized Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial and its Follow-up Study","volume":"11","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuron.2019.02.027_bib3","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial","volume":"289","author":"Aisen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neuron.2019.02.027_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2019.02.027_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.nbd.2018.11.011","article-title":"Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice","volume":"124","author":"Arrant","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2019.02.027_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mt.2014.180","article-title":"Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice","volume":"23","author":"Ayers","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuron.2019.02.027_bib7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2019.02.027_bib8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/eji.200636195","article-title":"You say ITAM and I say ITIM, let\u2019s call the whole thing off: the ambiguity of immunoreceptor signalling","volume":"36","author":"Barrow","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuron.2019.02.027_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jalz.2016.07.005","article-title":"The DIAN-TU Next Generation Alzheimer\u2019s prevention trial: adaptive design and disease progression model","volume":"13","author":"Bateman","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuron.2019.02.027_bib10","doi-asserted-by":"crossref","DOI":"10.1159\/000493018","article-title":"Advances and current challenges associated with the use of human induced pluripotent stem cells in modeling neurodegenerative disease","author":"Berry","year":"2018","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.neuron.2019.02.027_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2019.02.027_bib12","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.44.2.227","article-title":"Inverse association of anti-inflammatory treatments and Alzheimer\u2019s disease: initial results of a co-twin control study","volume":"44","author":"Breitner","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2019.02.027_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0197-4580(95)00049-K","article-title":"Delayed onset of Alzheimer\u2019s disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs","volume":"16","author":"Breitner","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2019.02.027_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","article-title":"Extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial","volume":"7","author":"Breitner","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuron.2019.02.027_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/mp.2011.24","article-title":"Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b\/C4b binding sites","volume":"17","author":"Brouwers","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2019.02.027_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jalz.2016.10.005","article-title":"A\u00a0candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer\u2019s disease risk and increased TREML1 and TREM2 brain gene expression","volume":"13","author":"Carrasquillo","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuron.2019.02.027_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijms18050993","article-title":"Molecular imaging of neuroinflammation in neurodegenerative dementias: the role of in\u00a0vivo PET imaging","volume":"18","author":"Cerami","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuron.2019.02.027_bib19","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.4049\/jimmunol.0903382","article-title":"IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice","volume":"184","author":"Chakrabarty","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuron.2019.02.027_bib20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.2829","article-title":"Interferon-\u03b3 induces progressive nigrostriatal degeneration and basal ganglia calcification","volume":"14","author":"Chakrabarty","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","article-title":"IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior","volume":"85","author":"Chakrabarty","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2019.02.027_bib22","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2019.02.027_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri1106","article-title":"TREMs in the immune system and beyond","volume":"3","author":"Colonna","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuron.2019.02.027_bib24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nature05017","article-title":"Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21","volume":"442","author":"Cruts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2019.02.027_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuron.2019.02.027_bib26","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1172\/JCI58656","article-title":"The immunology of neurodegeneration","volume":"122","author":"Czirr","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuron.2019.02.027_bib27","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib28","doi-asserted-by":"crossref","first-page":"e1475","DOI":"10.1371\/journal.pone.0001475","article-title":"No effect of one-year treatment with indomethacin on Alzheimer\u2019s disease progression: a randomized controlled trial","volume":"3","author":"de Jong","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2019.02.027_bib29","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.2950593","article-title":"\u03b2 amyloid gene duplication in Alzheimer\u2019s disease and karyotypically normal Down syndrome","volume":"235","author":"Delabar","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.neuron.2019.02.027_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Doody","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib31","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.stemcr.2017.04.023","article-title":"Directed differentiation of human pluripotent stem cells to microglia","volume":"8","author":"Douvaras","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.neuron.2019.02.027_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fneur.2018.00625","article-title":"In\u00a0vivo imaging of glial activation in Alzheimer\u2019s disease","volume":"9","author":"Edison","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuron.2019.02.027_bib33","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/exnr.1998.6920","article-title":"Inflammation and Alzheimer\u2019s disease: relationships between pathogenic mechanisms and clinical expression","volume":"154","author":"Eikelenboom","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuron.2019.02.027_bib35","doi-asserted-by":"crossref","first-page":"e12832","DOI":"10.1111\/acel.12832","article-title":"Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice","volume":"17","author":"Elmore","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuron.2019.02.027_bib36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1172\/JCI18162","article-title":"NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in\u00a0vivo","volume":"112","author":"Eriksen","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuron.2019.02.027_bib37","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib38","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1523\/JNEUROSCI.6103-11.2013","article-title":"Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice","volume":"33","author":"Filiano","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.immuni.2018.04.016","article-title":"The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity","volume":"48","author":"Filipello","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.neuron.2019.02.027_bib40","doi-asserted-by":"crossref","first-page":"e8808","DOI":"10.1371\/journal.pone.0008808","article-title":"MHC class II molecules enhance Toll-like receptor mediated innate immune responses","volume":"5","author":"Frei","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2019.02.027_bib41","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.celrep.2018.07.094","article-title":"Human induced pluripotent stem cell-derived microglia-like cells harboring TREM2 missense mutations show specific deficits in phagocytosis","volume":"24","author":"Garcia-Reitboeck","year":"2018","journal-title":"Cell Rep."},{"issue":"Suppl 2","key":"10.1016\/j.neuron.2019.02.027_bib42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/jnc.13583","article-title":"Overcoming translational barriers impeding development of Alzheimer\u2019s disease modifying therapies","volume":"139","author":"Golde","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuron.2019.02.027_bib43","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1172\/JCI66029","article-title":"Thinking laterally about neurodegenerative proteinopathies","volume":"123","author":"Golde","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuron.2019.02.027_bib44","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1016\/j.febslet.2011.08.033","article-title":"Role of microglia in CNS inflammation","volume":"585","author":"Graeber","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuron.2019.02.027_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","article-title":"Glial-neuronal interactions in Alzheimer\u2019s disease: the potential role of a \u2018cytokine cycle\u2019 in disease progression","volume":"8","author":"Griffin","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuron.2019.02.027_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology","volume":"85","author":"Guillot-Sestier","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2019.02.027_bib48","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.stemcr.2017.05.017","article-title":"A\u00a0highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response","volume":"8","author":"Haenseler","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.neuron.2019.02.027_bib49","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","article-title":"Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease","volume":"42","author":"Hamza","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2019.02.027_bib50","doi-asserted-by":"crossref","first-page":"41802","DOI":"10.1038\/srep41802","article-title":"Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota","volume":"7","author":"Harach","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2019.02.027_bib51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuron.2019.02.027_bib52","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00401-017-1737-3","article-title":"Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer\u2019s pathology","volume":"134","author":"Haure-Mirande","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2019.02.027_bib53","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2019.02.027_bib54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuron.2019.02.027_bib55","doi-asserted-by":"crossref","first-page":"e27109","DOI":"10.1371\/journal.pone.0027109","article-title":"Evidence for more than one Parkinson\u2019s disease-associated variant within the HLA region","volume":"6","author":"Hill-Burns","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2019.02.027_bib56","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nn.4587","article-title":"A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer\u2019s disease","volume":"20","author":"Huang","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0197-4580(98)00096-7","article-title":"NSAIDs and incident Alzheimer\u2019s disease. The Rotterdam Study","volume":"19","author":"in \u2019t Veld","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2019.02.027_bib58","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jalz.2014.05.1757","article-title":"Convergent genetic and expression data implicate immunity in Alzheimer\u2019s disease","volume":"11","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuron.2019.02.027_bib59","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2019.02.027_bib60","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1523\/JNEUROSCI.22-06-02246.2002","article-title":"Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice","volume":"22","author":"Jantzen","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib62","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrn.2017.36","article-title":"Progranulin, lysosomal regulation and neurodegenerative disease","volume":"18","author":"Kao","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neurobiolaging.2018.10.017","article-title":"Translating Alzheimer\u2019s disease-associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs","volume":"74","author":"Katsumata","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2019.02.027_bib64","doi-asserted-by":"crossref","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib65","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/jamaneurol.2015.0979","article-title":"R47H variant of TREM2 associated with Alzheimer disease in a large late-onset\u00a0family: clinical, genetic, and neuropathological study","volume":"72","author":"Korvatska","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuron.2019.02.027_bib66","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/gerona\/gls187","article-title":"The role of peripheral inflammatory markers in dementia and Alzheimer\u2019s disease: a meta-analysis","volume":"68","author":"Koyama","year":"2013","journal-title":"J.\u00a0Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.neuron.2019.02.027_bib67","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm1235","article-title":"Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production","volume":"11","author":"Kukar","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev-med-050715-104343","article-title":"Innate immunity and neurodegeneration","volume":"69","author":"Labzin","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib69","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2019.02.027_bib70","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3233\/JAD-2010-100018","article-title":"Implication of the immune system in Alzheimer\u2019s disease: evidence from genome-wide pathway analysis","volume":"20","author":"Lambert","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuron.2019.02.027_bib71","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2353\/ajpath.2010.100265","article-title":"CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer\u2019s disease mouse models","volume":"177","author":"Lee","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuron.2019.02.027_bib72","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","article-title":"Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer\u2019s disease models","volume":"97","author":"Lee","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2019.02.027_bib73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.15252\/emmm.201809027","article-title":"High-affinity interactions and signal transduction between A\u03b2 oligomers and TREM2","volume":"10","author":"Lessard","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib74","doi-asserted-by":"crossref","first-page":"11524","DOI":"10.1073\/pnas.1710311114","article-title":"TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy","volume":"114","author":"Leyns","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2019.02.027_bib75","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002510100339","article-title":"Structural organization of the human MS4A gene cluster on chromosome 11q12","volume":"53","author":"Liang","year":"2001","journal-title":"Immunogenetics"},{"key":"10.1016\/j.neuron.2019.02.027_bib76","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer\u2019s disease","volume":"20","author":"Lim","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib77","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/glia.22359","article-title":"Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx","volume":"61","author":"Linnartz","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neuron.2019.02.027_bib78","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neulet.2018.08.038","article-title":"Soluble TREM2 changes during the clinical course of Alzheimer\u2019s disease: a meta-analysis","volume":"686","author":"Liu","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuron.2019.02.027_bib79","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","article-title":"Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation","volume":"165","author":"Lui","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2019.02.027_bib80","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/01.wnl.0000260269.93245.d2","article-title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","volume":"68","author":"Lyketsos","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2019.02.027_bib81","article-title":"Alzheimer\u2019s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph","author":"Magno","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuron.2019.02.027_bib82","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2362.1996.159291.x","article-title":"Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice","volume":"26","author":"Malle","year":"1996","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.neuron.2019.02.027_bib83","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2559.1988.tb02018.x","article-title":"Alzheimer\u2019s disease and Down\u2019s syndrome","volume":"13","author":"Mann","year":"1988","journal-title":"Histopathology"},{"key":"10.1016\/j.neuron.2019.02.027_bib84","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2019.02.027_bib85","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1172\/JCI63113","article-title":"Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury","volume":"122","author":"Martens","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuron.2019.02.027_bib86","doi-asserted-by":"crossref","first-page":"25663","DOI":"10.1038\/srep25663","article-title":"CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves","volume":"6","author":"Mart\u00ednez-Muriana","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2019.02.027_bib87","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.molmed.2017.04.005","article-title":"Should we stop saying \u2018glia\u2019 and \u2018neuroinflammation\u2019?","volume":"23","author":"Masgrau","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib88","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2019.02.027_bib89","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00002093-199408030-00001","article-title":"Neuroimmune mechanisms in Alzheimer disease pathogenesis","volume":"8","author":"McGeer","year":"1994","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neuron.2019.02.027_bib90","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer\u2019s disease: a review of 17 epidemiologic studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2019.02.027_bib91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"A\u00a0controlled trial of natalizumab for relapsing multiple sclerosis","volume":"348","author":"Miller","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib92","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3672","article-title":"Progranulin protects against amyloid \u03b2 deposition and toxicity in Alzheimer\u2019s disease mouse models","volume":"20","author":"Minami","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib93","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1038\/s41598-017-11047-w","article-title":"Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE\/PS1\u0394E9 murine model of Alzheimer\u2019s disease","volume":"7","author":"Minter","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2019.02.027_bib94","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ajmg.b.32100","article-title":"CSF1R mutations identified in three families with autosomal dominantly inherited leukoencephalopathy","volume":"159B","author":"Mitsui","year":"2012","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuron.2019.02.027_bib95","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","article-title":"Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial","volume":"130","author":"Moreland","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib96","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2019.02.027_bib97","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9440(10)62251-1","article-title":"Brain and bone damage in KARAP\/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages","volume":"166","author":"Nataf","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuron.2019.02.027_bib98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2006.11.032","article-title":"Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis","volume":"184","author":"Neumann","year":"2007","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuron.2019.02.027_bib99","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/awv379","article-title":"Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology","volume":"139","author":"Olmos-Alonso","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuron.2019.02.027_bib100","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib101","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","article-title":"A phase III randomized trial of gantenerumab in prodromal Alzheimer\u2019s disease","volume":"9","author":"Ostrowitzki","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuron.2019.02.027_bib102","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.1102836","article-title":"TREM2 and \u03b2-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis","volume":"188","author":"Otero","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuron.2019.02.027_bib103","series-title":"GeneReviews","article-title":"Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL)","author":"Paloneva","year":"1993"},{"key":"10.1016\/j.neuron.2019.02.027_bib104","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/342259","article-title":"Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype","volume":"71","author":"Paloneva","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuron.2019.02.027_bib105","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","article-title":"A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer\u2019s disease","volume":"21","author":"Park","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib106","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease","volume":"10","author":"Perry","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuron.2019.02.027_bib107","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","article-title":"Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status","volume":"131","author":"Piccio","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2019.02.027_bib108","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn.4475","article-title":"The role of peripheral immune cells in the CNS in steady state and disease","volume":"20","author":"Prinz","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib109","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ng.1027","article-title":"Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids","volume":"44","author":"Rademakers","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2019.02.027_bib110","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist?","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib111","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neurobiolaging.2018.10.022","article-title":"CSF soluble TREM2 as a\u00a0measure of immune response along the Alzheimer\u2019s disease continuum","volume":"74","author":"Rauchmann","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"Suppl 3","key":"10.1016\/j.neuron.2019.02.027_bib112","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-2011-0059","article-title":"Alzheimer\u2019s Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments","volume":"26","author":"Reiman","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuron.2019.02.027_bib113","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"Rofecoxib: no effect on Alzheimer\u2019s disease in a 1-year, randomized, blinded, controlled study","volume":"62","author":"Reines","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2019.02.027_bib114","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jama.2013.2973","article-title":"Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E \u03b54,and the risk of late-onset Alzheimer disease in African Americans","volume":"309","author":"Reitz","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.neuron.2019.02.027_bib115","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0197-4580(96)00115-7","article-title":"Inflammation and Alzheimer\u2019s disease pathogenesis","volume":"17","author":"Rogers","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2019.02.027_bib116","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","article-title":"Serum amyloid A - a review","volume":"24","author":"Sack","year":"2018","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib117","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2019.02.027_bib118","doi-asserted-by":"crossref","first-page":"10172","DOI":"10.1073\/pnas.1811411115","article-title":"Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy","volume":"115","author":"Sayed","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2019.02.027_bib119","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.15252\/emmm.201707672","article-title":"An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function","volume":"9","author":"Schlepckow","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2019.02.027_bib121","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuron.2009.09.044","article-title":"MHC class I: an unexpected role in neuronal plasticity","volume":"64","author":"Shatz","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2019.02.027_bib122","doi-asserted-by":"crossref","first-page":"15312","DOI":"10.1074\/jbc.M117.799346","article-title":"The Alzheimer\u2019s disease-protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool","volume":"292","author":"Siddiqui","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2019.02.027_bib123","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ng.3916","article-title":"Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease","volume":"49","author":"Sims","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2019.02.027_bib124","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature13138","article-title":"Obesity-associated variants within FTO form long-range functional connections with IRX3","volume":"507","author":"Smemo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2019.02.027_bib125","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuron.2019.02.027_bib126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000096588","article-title":"Long-term efficacy and safety of celecoxib in Alzheimer\u2019s disease","volume":"23","author":"Soininen","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neuron.2019.02.027_bib127","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.20171529","article-title":"Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism","volume":"215","author":"Song","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib128","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp.74.6.825-a","article-title":"An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene","volume":"74","author":"Soragna","year":"2003","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuron.2019.02.027_bib129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","article-title":"Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease","volume":"13","author":"Sosna","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2019.02.027_bib130","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/brain\/aww016","article-title":"Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology","volume":"139","author":"Spangenberg","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuron.2019.02.027_bib131","doi-asserted-by":"crossref","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib132","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10072-016-2634-6","article-title":"Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): update on molecular genetics","volume":"37","author":"Stabile","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuron.2019.02.027_bib133","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.48.3.626","article-title":"Risk of Alzheimer\u2019s disease and duration of NSAID use","volume":"48","author":"Stewart","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2019.02.027_bib134","doi-asserted-by":"crossref","first-page":"369ra178","DOI":"10.1126\/scitranslmed.aag1767","article-title":"Early changes in CSF sTREM2 in dominantly inherited Alzheimer\u2019s disease occur after amyloid deposition and neuronal injury","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib136","doi-asserted-by":"crossref","first-page":"e9712","DOI":"10.15252\/emmm.201809712","article-title":"CSF progranulin increases in the course of Alzheimer\u2019s disease and is associated with sTREM2, neurodegeneration and cognitive decline","volume":"10","author":"Su\u00e1rez-Calvet","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuron.2019.02.027_bib137","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in Alzheimer\u2019s disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2019.02.027_bib138","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.06.017","article-title":"Induced-pluripotent-stem-cell-derived primitive macrophages provide a platform for modeling tissue-resident macrophage differentiation and function","volume":"47","author":"Takata","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neuron.2019.02.027_bib139","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cmet.2014.09.010","article-title":"Obesity and FTO: changing focus at a complex locus","volume":"20","author":"Tung","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuron.2019.02.027_bib140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 - a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuron.2019.02.027_bib141","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","article-title":"Elucidating the role of TREM2 in Alzheimer\u2019s disease","volume":"94","author":"Ulrich","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2019.02.027_bib142","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2019.02.027_bib143","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2019.02.027_bib144","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","article-title":"Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial","volume":"48","author":"Weinblatt","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuron.2019.02.027_bib145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","article-title":"Innate immune memory in the brain shapes neurological disease hallmarks","volume":"556","author":"Wendeln","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2019.02.027_bib146","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajhg.2013.10.009","article-title":"Association of Parkinson disease with structural and regulatory variants in the HLA region","volume":"93","author":"Wissemann","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuron.2019.02.027_bib147","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between Parkinson disease and autoimmune diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuron.2019.02.027_bib148","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13024-018-0280-6","article-title":"The Trem2 R47H Alzheimer\u2019s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans","volume":"13","author":"Xiang","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2019.02.027_bib149","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0197-4580(01)00297-4","article-title":"Do NSAIDs prevent Alzheimer\u2019s disease? And, if so, why? The epidemiological evidence","volume":"22","author":"Zandi","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2019.02.027_bib150","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2019.02.027_bib151","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","article-title":"Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse","volume":"89","author":"Zhang","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2019.02.027_bib152","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 is a receptor for \u03b2-amyloid that mediates microglial function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2019.02.027_bib153","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","article-title":"A hypermorphic missense mutation in PLCG2, encoding phospholipase C\u03b32, causes a dominantly inherited autoinflammatory disease with immunodeficiency","volume":"91","author":"Zhou","year":"2012","journal-title":"Am. J. Hum. Genet."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089662731930162X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089662731930162X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:18:01Z","timestamp":1760253481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089662731930162X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":153,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S089662731930162X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2019.02.027","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2019.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}